The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hcg and alpha-fetoprotein

Obstetrics and Gynecology

Volumn 89, Issue 5, 1997, Pages 666-670

  Morssink, Leonard P ^a   Heringa, Martijn P ^a   Beekhuis, Johan R ^a   De Wolf, Ben T H M ^a   Mantingh, Albert ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; RISK FACTORS;

EID: 0030893416     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00088-4     Document Type: Article

References (21)

1. Simpson JL, Shulman L, Dungan J, Phillips O, Elias S. Mid-trimester biochemistry in prediction of third trimester complications. In: Grudzinskas G, Chard T, Chapman M, Cuckle H, eds. Screening for Down's syndrome. Cambridge: Cambridge University Press, 1994:325-38.
2. Morssink LP, Kornman LH, Beekhuis JR, de Wolf BTHM, Mantingh A. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester; rela-tion with fetal weight and preterm delivery. Prenat Diagn 1995;15: 1041-6.
3. Boyd PA. Why might maternal serum AFP be high in pregnancies in which the fetus is normally formed? Br J Obstet Gynaecol 1992;99:93-5.
4. Morssink LP, de Wolf BTHM, Kornman LH, Beekhuis JR, van der Hall TPJ, Mantingh A. The relation between serum markers in the second trimester and placental pathology. A study on extremely small-for-gestational-age fetuses. Br J Obstet Gynaecol 1996;103: 779-83.
5. Brosens I, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of pre-eclampsia. Obstet Gynecol Annu 1972; 1:177-80.
6. Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 1981;88:876-81.
7. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158:892-8.
8. Kloosterman GJ. On intrauterine growth. The significance of prenatal care. Int J Gynaecol Obstet 1970;8:895-912.
9. Hamilton MPR, Abdalla HI, Whitfield CR. Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses. Obstet Gynecol 1985;65:465-70.
10. Milunsky A, Jick SS, Bruell CL, MacLaughlin DS, Tsung YK, Jick H, et al. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: New epidemiologic data. Am J Obstet Gynecol 1989; 161:291-7.
11. Tanaka M, Natori M, Kohno H, Ishimoto H, Kobayashi T, Nozawa S. Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol 1993;81:341-3.
12. Brazerol WF, Grover S, Donnenfeld AE. Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol 1994;171:1030-5.
13. Wenstrom KD, Owen J, Davis RO, Brumfield CG. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol 1996;87:213-6.
14. Walters BNJ, Lao T, Smith V, de Swiet M. Alpha-fetoprotein elevation and proteinuric pre-eclampsia. Br J Obstet Gynaecol 1985;92:341-4.
15. Hsu CD, Chan DW, Iriye B, Johnson TRB, Hong SF, Repke JT. Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia. Am J Obstet Gynecol 1994;170:1135-8.
16. Benn PA, Horse D, Briganti S, Rodis JF, Clive JM. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol 1996;87:217-22.
17. Muller F, Savey L, Le Fiblec B, Bussieres L, Ndayizamba G, Colau JC, et al. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol 1996;175:37-40.
18. Wenstrom KD, Owen J, Boots LR, DuBard MB. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol 1994;171:1038-41.
19. Schrocksnadel H, Daxenbichler G, Artner E, Steckel-Berger G, Dapunt O. Tumor markers in hypertensive disorders of pregnancy. Gynecol Obstet Invest 1993;35:204-8.
20. Fox H, Path MC. Effect of hypoxia on trophoblast in organ culture. A morphologic and autoradiographic study. Am J Obstet Gynecol 1970;107:1058-64.
21. Hay DL. Placental histology and the production of human cho-riogonadotrophin and its subunits in pregnancy. Br J Obstet Gynaecol 1988;95:1268-75.